Fordeling Da den systemiske eksponering er lav ved behandling med tacrolimus salve, er den kraftige plasmabinding af tacrolimus (> 98, 8%) næppe klinisk relevant.
Distribution As systemic exposure is low with tacrolimus ointment, the high binding of tacrolimus (> 98.8%) to plasma proteins is considered not to be clinically relevant.